Scientific article


Published inRevue médicale suisse, vol. 6, no. 231, p. 56-60,62
Publication date2010

Fracture risk could be evaluated with FRAX. Vitamin D administration decreases the rate of falls and deaths. Denosumab reduces the risk of fracture in postmenopausal women with osteoporosis and shows positive effects in case of breast and prostate cancers with hormone deprivation therapies. Zoledronate and teriparatide alone are more effective than risedronate and alendronate respectively in treatment of glucocorticoids induced osteoporosis. The association zoledronate and teriparatide may be promising. Vertebroplasty is not the first line treatment for symptomatic osteoporotic vertebral fractures. Osteonecrosis of the jaw and subtrochanteric femoral fractures are still events to consider in case of treatments with bisphosphonates.

  • Bone Density Conservation Agents/therapeutic use
  • Female
  • Fractures, Bone/etiology/prevention & control
  • Humans
  • Osteoporosis, Postmenopausal/complications/drug therapy
Research group
Citation (ISO format)
UEBELHART, Brigitte Florence, RIZZOLI, René. Ostéoporose. In: Revue médicale suisse, 2010, vol. 6, n° 231, p. 56–60,62.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation12/05/2013 11:25:00 AM
First validation12/05/2013 11:25:00 AM
Update time03/14/2023 8:50:17 PM
Status update03/14/2023 8:50:17 PM
Last indexation01/16/2024 8:50:48 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack